INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "COMPOUND FOR USE IN THE TREATMENT OF DEPRESSION, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER AND/OR BORDERLINE PERSONALITY DISORDER"

GENEVA, Nov. 17 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2025/062166) for "COMPOUND FOR USE IN THE TREATMENT OF DEPRESSION, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER AND/OR BORDERLINE PERSONALITY DISORDER" on May 05, 2025. With publication no. WO/2025/233259, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE CRESCENZO, Franco (Boehringer Ingelheim International GmbHGlobal PatentsBinger Strasse 17355216 Ingelheim am Rhein)...